Cognigenics Leading Edge
Cognigenics researchers are developing a new science for improving human behavior and cognition by genetically optimizing brain functioning. Genetic neuropsychology combines neuroscience, cognitive psychology and genetic engineering to treat neurological disorders. These disorders usually involve imbalances in various brain regions, and by normalizing the unbalanced areas with CRISPR, a disorder’s behavioral and cognitive effects can be mitigated.
This new science is made possible by a revolutionary new form of CRISPR called CRISPR-T, which can dynamically deliver genome edits to most brain regions. This highly flexible technology can use any form of CRISPR to modify any neuron gene or RNA transcript and represents a foundational science breakthrough.
Treatable neurological conditions include attention deficit disorder (ADD), obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), anxiety, depression, psychosomatic issues, memory concerns, Alzheimer's disease symptoms, tinnitus and mild cognitive impairment (MCI).
Genetic neuropsychology can also be used for cognitive enhancement to raise conscious awareness, decrease inattention, reduce mind-wandering, lower craving, sharpen mental focus, increase concentration, enhance mindfulness, increase intuition and foster emotional balance.